Trending

Brian Kieser, CEO of Nvision Biomedical Technologies, on How Vertical

Brian More, CEO of Nanovis, on Nanotechnology, Focused Execution, and

AI for Stroke: A Conversation with Brad Wittenberg from Brainomix

Monica Burt on Why Most MedTech Companies Are Doing Quality

Tariff Talks: One-on-One with Tim Sheehan, BlackPoint Capital Markets, Managing

August 6, 2025
    Medtech Momentum, schedule a meeting
    Subscribe
    Notification
    Latest News

    Brian Kieser, CEO of Nvision Biomedical Technologies, on How Vertical Integration Became the Company’s Superpower

    Jun 02, 2025

    Brian More, CEO of Nanovis, on Nanotechnology, Focused Execution, and Strategic Growth

    May 01, 2025

    AI for Stroke: A Conversation with Brad Wittenberg from Brainomix

    Apr 29, 2025

    Monica Burt on Why Most MedTech Companies Are Doing Quality All Wrong—and How to Fix It Before It Breaks You

    Apr 18, 2025
    The MedTech Digest > MedTech Leaders
    02
    Jun

    Brian Kieser, CEO of Nvision Biomedical Technologies, on How Vertical Integration Became the Company’s Superpower

    • Guillaume Viallaneix / 2 months
    • 8 min read

    Some of the most innovative leaders in the Medical Technology industry don’t arrive there through a straight line, and that’s certainly the case with Brian Kieser. Before founding Nvision Biomedical Technologies and building one of the most integrated innovation ecosystems in the industry, Brian was a mechanical engineering student, then an accountant, and eventually a certified public accountant (CPA) at KPMG. From technical schematics to financial audits, he’s seen every layer of how a business is built successfully.

    01
    May

    Brian More, CEO of Nanovis, on Nanotechnology, Focused Execution, and Strategic Growth

    • Guillaume Viallaneix / 3 months
    • 7 min read

    We sit down with Brian More, CEO of Nanovis, for a candid conversation on strategy, science, and scaling up smart. From startup grit to a groundbreaking collaboration with Medtronic, Brian shares how Nanovis is transforming orthopedic and spinal implants through surface-level innovation, and why staying focused is the key to long-term success.

    29
    Apr

    AI for Stroke: A Conversation with Brad Wittenberg from Brainomix

    • Guillaume Viallaneix / 3 months
    • 6 min read

    Founded as a spin-out from the University of Oxford, Brainomix has already transformed stroke care across Europe. With more than 70% market share in the UK and over 60 peer-reviewed publications validating its efficacy in real world settings, the company has delivered what few others can: evidence-based, scalable AI that improves outcomes and makes stroke systems more efficient.

    18
    Apr

    Monica Burt on Why Most MedTech Companies Are Doing Quality All Wrong—and How to Fix It Before It Breaks You

    • Guillaume Viallaneix / 4 months
    • 5 min read

    “We often joke that we’re the Green Berets of quality,” says Monica Burt, founder of MB&A. “When things go sideways—an FDA audit is imminent, a system is unraveling, or a product launch is on life support—we get the call.”In this candid conversation with The MedTech Digest, Monica Burt pulls back the curtain on why most MedTech companies are doing quality all wrong—and how her team is helping them fix it before it breaks them. From debunking the myth that more paperwork equals more compliance, to rebuilding systems that actually enable innovation, Burt’s insights are equal parts sharp, strategic, and human.

    15
    Apr

    Tariff Talks: One-on-One with Tim Sheehan, BlackPoint Capital Markets, Managing Director – Episode 1, Part 2

    • Guillaume Viallaneix / 4 months
    • 6 min read

    MedTech companies from both sides of the Atlantic kept reaching out to us since the beginning of the year, worried about what was happening in the U.S. with the new administration and how it might affect their business. They wanted guidance, insights, and most importantly, an educated path forward.

    10
    Apr

    Tariff Talks: One-on-One with Tim Sheehan, BlackPoint Capital Markets, Managing Director – Episode 1, Part 1

    • Guillaume Viallaneix / 4 months
    • 10 min read

    MedTech companies from both sides of the Atlantic kept reaching out to us since the beginning of the year, worried about what was happening in the U.S. with the new administration and how it might affect their business. They wanted guidance, insights, and most importantly, an educated path forward.

    Cody Simmons
    22
    May

    Exclusive Interview: A Look Inside DermaSensor’s Journey to Innovation with CEO, Cody Simmons

    • Guillaume Viallaneix / 1 year
    • 16 min read

    I’ve learned and shared with people that whenever you have a major setback – whether study-related, study timeline change or product setback and timeline change, just reevaluate your whole approach and strategy because even with your well-laid plans, when one of the pieces of the plan changes, you realize other doors could open.